https://thepharmadata.com/bayer-extends-partnership-with-peking-university-to-foster-pharmaceutical-innovation-in-china/ 2023-07-11T11:14:14+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/partnership.webp https://thepharmadata.com/leadership-in-emergencies-learning-journey-completed-by-new-afro-cohort/ 2023-07-11T11:12:24+00:00 https://thepharmadata.com/wp-content/uploads/2023/07/Leadership.webp https://thepharmadata.com/european-commission-approves-roches-fixed-duration-columvi-glofitamab-for-people-with-relapsed-or-refractory-diffuse-large-b-cell-lymphoma/ 2023-07-11T11:11:05+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/lymphoma.webp https://thepharmadata.com/syneos-health-appoints-hillary-bochniak-as-chief-human-resources-officer/ 2023-07-11T11:09:32+00:00 https://thepharmadata.com/wp-content/uploads/2023/07/Appoints-_3_.webp https://thepharmadata.com/medicines-and-healthcare-products-regulatory-agency-authorizes-g-sks-arexvy-the-first-respiratory-syncytial-virus-rsv-vaccine-for-older-adults/ 2023-07-11T11:02:40+00:00 https://thepharmadata.com/wp-content/uploads/2023/07/Medicines-_2_.webp https://thepharmadata.com/unlocking-the-mystery-of-long-lasting-cancer-treatment/ 2023-07-07T11:07:21+00:00 https://thepharmadata.com/wp-content/uploads/2023/07/cancer-treatment.webp https://thepharmadata.com/artificial-cells-demonstrate-that-life-finds-a-way/ 2023-07-07T11:04:38+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Science-Research.webp https://thepharmadata.com/teva-to-host-conference-call-to-discuss-second-quarter-2023-financial-results-at-8-a-m-et-on-august-2-2023/ 2023-07-07T11:00:50+00:00 https://thepharmadata.com/wp-content/uploads/2023/07/Conference.webp https://thepharmadata.com/women-and-girls-bear-brunt-of-water-and-sanitation-crisis-new-unicef-who-report/ 2023-07-07T10:38:43+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/report-_2_.webp https://thepharmadata.com/syneos-health-strengthens-asia-pacific-leadership/ 2023-07-03T05:02:42+00:00 https://thepharmadata.com/wp-content/uploads/2023/07/Leadership.webp https://thepharmadata.com/who-regional-adviser-for-prevention-and-response-to-sexual-misconduct-in-south-east-asia/ 2023-07-03T04:54:27+00:00 https://thepharmadata.com/wp-content/uploads/2023/07/WHO-_4_.webp https://thepharmadata.com/the-new-approach-in-cancer-therapy-with-innovative-mechanism-of-action-for-ferroptosis-induction/ 2023-07-03T04:48:07+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/cancer.webp https://thepharmadata.com/fda-approves-pfizers-ngenla-a-long-acting-once-weekly-treatment-for-pediatric-growth-hormone-deficiency/ 2023-06-29T05:28:09+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/Pediatric.webp https://thepharmadata.com/astrazeneca-announces-400-million-investment-in-reforestation-and-biodiversity-in-support-of-climate-action-and-human-health/ 2023-06-29T05:18:23+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Announces-2-1.webp https://thepharmadata.com/abbvie-and-genmab-announce-positive-topline-results-from-phase-1-2-epcore-nhl-1-trial-evaluating-epcoritamab-duobody-cd3xcd20-in-patients-with-relapsed-refractory-follicular-lymphoma/ 2023-06-29T05:15:41+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/Positive.webp https://thepharmadata.com/fda-approves-pfizers-litfulo-ritlecitinib-for-adults-and-adolescents-with-severe-alopecia-areata/ 2023-06-27T04:44:35+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/approves-_2_.webp https://thepharmadata.com/magdeburg-researchers-discover-a-new-mechanism-of-cancer-immune-defense/ 2023-06-27T04:32:05+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/researcher.webp https://thepharmadata.com/the-first-year-of-the-long-covid-project-what-has-been-achieved/ 2023-06-23T05:50:37+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/pexels-anna-shvets-3786126-_1_.webp https://thepharmadata.com/kite-announces-completion-of-marketing-authorization-transfer-for-yescarta-car-t-cell-therapy-in-japan/ 2023-06-23T05:42:06+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/Therapy-_3_.webp https://thepharmadata.com/ad-hoc-announcement-pursuant-to-art-53-lrferring-pharmaceuticals-appoints-new-executive-chairman-among-key-changes-to-board-of-directors/ 2023-06-23T05:39:29+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Announcement.webp https://thepharmadata.com/who-and-global-citizen-sign-a-partnership-to-promote-health-fight-inequity-and-address-health-related-risks-of-climate-change/ 2023-06-23T05:35:55+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/partnership.webp https://thepharmadata.com/pfizers-talzenna-in-combination-with-xtandi-receives-u-s-fda-approval/ 2023-06-22T09:23:15+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/approval.webp https://thepharmadata.com/new-anti-coagulants-may-help-treat-sepsis-and-covid-19/ 2023-06-22T09:21:14+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/COVID-19.webp https://thepharmadata.com/for-resistant-breast-cancers-two-drugs-may-be-better-than-one/ 2023-06-20T04:22:21+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/pexels-tara-winstead-7723582.webp https://thepharmadata.com/first-of-its-kind-head-to-head-clinical-trial-reaffirms-the-efficacy-of-emgality-in-episodic-migraine-prevention/ 2023-06-19T05:07:56+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/Clinical-_3_.webp https://thepharmadata.com/rabat-declaration-adopted-to-improve-refugee-and-migrant-health/ 2023-06-19T05:02:27+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/adopted-_2_.webp https://thepharmadata.com/people-with-medical-needs-are-left-behind-in-pain-reveals-new-report/ 2023-06-19T04:58:39+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/report-_2_.webp https://thepharmadata.com/scientists-discover-small-rna-that-regulates-bacterial-infection/ 2023-06-15T04:09:21+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/bacterial-infection.webp https://thepharmadata.com/bayer-to-acquire-exclusive-license-from-cedilla-therapeutics-on-selective-inhibitors-in-pre-clinical-precision-oncology/ 2023-06-14T10:42:16+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/Oncology-2.webp https://thepharmadata.com/new-clinical-handbook-launched-to-support-quality-abortion-care/ 2023-06-12T04:56:19+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/clinical-_2_.webp https://thepharmadata.com/boehringer-ingelheim-and-zealand-pharma-announce-phase-ii-trial-showed-14-9-weight-loss-in-people-living-with-obesity-or-overweight/ 2023-06-12T04:45:11+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/weight-loss-_2_.webp https://thepharmadata.com/taurine-may-be-a-key-to-longer-and-healthier-life/ 2023-06-09T04:13:03+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/healthier.webp https://thepharmadata.com/novo-nordisk/ 2023-06-08T11:54:41+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Announces.webp https://thepharmadata.com/european-commission-authorises-gsks-arexvy-the-first-respiratory-syncytial-virus-rsv-vaccine-for-older-adults/ 2023-06-08T05:19:27+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/vaccine-_2_.webp https://thepharmadata.com/bayer-strengthens-gene-therapy-portfolio-with-lipid-nanoparticle-technology-from-acuitas-therapeutics/ 2023-06-08T05:17:05+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/Acuitas-Therapeutics-_2_.webp https://thepharmadata.com/u-s-fda-approves-new-indication-for-mercks-prevymis-letermovir-for-prevention-of-cytomegalovirus-cmv-disease-in-high-risk-adult-kidney-transplant-recipients/ 2023-06-08T05:04:05+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/Kidney-Transplant.webp https://thepharmadata.com/moderna-and-merck-announces/ 2023-06-08T04:59:49+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Announcement.webp https://thepharmadata.com/gsk-receives-us-fda-file/ 2023-06-08T04:55:07+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/chemotherapy-_4_.webp https://thepharmadata.com/lymphoma/ 2023-06-08T04:47:17+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/Cell-Lymphoma.webp https://thepharmadata.com/breast-cancer/ 2023-06-07T11:31:39+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/cancer.webp https://thepharmadata.com/datopotamab-deruxtecan-combinations-showed-encouraging-tumorresponses-in-patients-with-advanced-non-small-cell-lung-cancer-intropion-lung02-phase-1b-trial/ 2023-06-07T11:28:34+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/lung-cancer.webp https://thepharmadata.com/catalent-expands-onebio-suite-for-integrated-development-manufacturing-and-supply-across-biologic-modalities/ 2023-06-07T11:25:24+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/Development.webp https://thepharmadata.com/who-announces-winners-of-the-4th-health-for-all-film-festival/ 2023-06-07T11:21:39+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Announces-2.webp https://thepharmadata.com/andexxa-phase-iv-trial-stopped-early-after-achieving-pre-specified-criteria-on-haemostatic-efficacy-versus-usual-care/ 2023-06-07T11:18:49+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/care.webp https://thepharmadata.com/amgen-presents-new-lumakras-sotorasib-codebreak-200-cns-data-at-asco-2023/ 2023-06-07T11:13:26+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/DATA.webp https://thepharmadata.com/fda-approves-first-over-the-counter-naloxone-nasal-spray/ 2023-06-03T07:11:59+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/naloxone-nasal-spray.webp https://thepharmadata.com/abbott-receives-fda-approval-for-its-spinal-cord-stimulation-systems-to-treat-chronic-back-pain-in-people-who-have-limited-surgical-options/ 2023-06-03T05:29:12+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/SPINAL-CORD.webp https://thepharmadata.com/gsks-respiratory-syncytial-virus/ 2023-06-03T05:27:09+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/vaccine-scaled.webp https://thepharmadata.com/fda-accepts-application-for-mercks-keytruda-pembrolizumab-plus-chemotherapy-as-first-line-treatment-for-locally-advanced-unresectable-or-metastatic-gastric-or-gastroesophageal-junctio/ 2023-06-03T05:22:54+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Application.webp https://thepharmadata.com/fda-accepts-pfizers-supplemental-new-drug-applications-for-braftovi-mektovi/ 2023-06-03T05:21:41+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Application-3-1.webp https://thepharmadata.com/regulatory-applications-accepted-across-three-regions-globally-for-abecma-for-earlier-use-in-adults-with-triple-class-exposed-relapsed-and-or-refractory-multiple-myeloma/ 2023-06-03T05:19:10+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Myeloma.webp https://thepharmadata.com/johnson-johnson-subsidiary-ltl-management-llc-ltl-re-files-for-voluntary-chapter-11-to-equitably-resolve-all-current-and-future-talc-claims/ 2023-06-03T05:18:45+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Re-Files.webp https://thepharmadata.com/moderna-and-merck-announce-mrna-4157-v940/ 2023-06-03T05:18:05+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Announces.webp https://thepharmadata.com/regeneron-and-alnylam-report-positive-interim-phase-1/ 2023-06-03T05:17:00+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/REPORT-scaled.webp https://thepharmadata.com/ultomiris-approved-in-the-eu-for-adults-with-neuromyelitis-optica-spectrum-disorder-nmosd/ 2023-06-03T05:16:01+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/approval.webp https://thepharmadata.com/lillys-social-impact-venture-capital-portfolio-poised-to-grow-to-300-million-with-new-50-million-allocation/ 2023-06-03T05:15:23+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/Portfolio.webp https://thepharmadata.com/fda-accepts-application-for-roches-vabysmo-for-the-treatment-of-retinal-vein-occlusion-rvo/ 2023-06-03T05:14:45+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/treatment-3.webp https://thepharmadata.com/dupixent-dupilumab-late-breaking-phase-3-copd-results-presented-at-ats-and-simultaneously-published-in-the-new-england-journal-of-medicine/ 2023-06-03T05:13:16+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/MEDICINE.webp https://thepharmadata.com/ultomiris-approved-in-japan-for-the-prevention-of-relapses-in-patients-with-neuromyelitis-optica-spectrum-disorder-nmosd/ 2023-06-03T05:12:26+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/disorder.webp https://thepharmadata.com/teva-presents-real-world/ 2023-06-03T05:08:55+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/Tablets.webp https://thepharmadata.com/sanofi-launches-2023-global-employee-stock-purchase-plan/ 2023-06-03T05:04:20+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/2023-global.webp https://thepharmadata.com/phase-3-studies-of-pfizers-novel-antibiotic-combination-offer-new-treatment-hope-for-patients-with-multidrug-resistant-infections-and-limited-treatment-options/ 2023-06-03T05:00:03+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/treatment.webp https://thepharmadata.com/novartis-receives-european-approval-for-cosentyx-as-first-and-only-il-17a-inhibitor-for-hidradenitis-suppurativa/ 2023-06-03T04:57:28+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/approval.webp https://thepharmadata.com/fda-approves/ 2023-06-03T04:55:43+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/Approves.webp https://thepharmadata.com/gilead-and-kite-oncology-demonstrate-growing-hematology-pipeline-and-strength-of-leading-cell-therapy-portfolio-at-eha/ 2023-06-03T04:50:48+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/Oncology-_3_.webp https://thepharmadata.com/lilly-highlights-verzenio-abemaciclib-and-jaypirca-pirtobrutinib-data-at-2023-asco-annual-meeting/ 2023-06-03T04:46:58+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/Meeting-_4_.webp https://thepharmadata.com/kate-eversteyn-joins-who-as-prseah-coordinator-for-europe/ 2023-06-03T04:41:29+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/joins.webp https://thepharmadata.com/world-health-assembly-recognizes-whos-work-on-prseah-calls-for-continued-action/ 2023-06-03T04:38:50+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/WHO-2.webp https://thepharmadata.com/who-launches-a-single-source-repository-on-drug-dependence-information/ 2023-06-03T04:36:39+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/drug-dependence.webp https://thepharmadata.com/imfinzi-plus-chemotherapy-significantly-improved-pathologic-complete-response-in-gastric-and-gastroesophageal-junction-cancers-in-matterhorn-phase-iii-trial/ 2023-06-03T04:32:38+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/chemotherapy-_3_.webp https://thepharmadata.com/lynparza-plus-abiraterone-approved-in-the-us-for-the-treatment-of-brca-mutated-metastatic-castration-resistant-prostate-cancer/ 2023-06-03T04:29:39+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/cancer.webp https://thepharmadata.com/phase-2-study-of-upadacitinib-rinvoq-alone-or-as-a-combination-therapy-meets-primary-and-key-secondary-endpoints-in-patients-with-systemic-lupus-erythematosus/ 2023-06-03T04:22:33+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/Therapy-_2_.webp https://thepharmadata.com/insilico-medicine-receives-ind-approval-for-novel-ai-designed-usp1-inhibitor-for-cancer/ 2023-06-03T04:18:38+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Approvals.webp https://thepharmadata.com/u-s-fda-approves-abrysvo-pfizers-vaccine-for-the-prevention-of-respiratory-syncytial-virus-rsv-in-older-adults/ 2023-06-03T04:17:33+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/vaccine-scaled.webp https://thepharmadata.com/pfizer-announces-positive-marstacimab-results-from-pivotal-phase-3-hemophilia-a-and-b-trial/ 2023-05-30T12:47:40+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Announces-2.webp https://thepharmadata.com/syneos-health-launches-medical-affairs-digital-amplifier/ 2023-05-30T12:45:42+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/medical.webp https://thepharmadata.com/new-wha-resolution-to-accelerate-efforts-on-food-micronutrient-fortification/ 2023-05-30T12:36:20+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/accelerate.webp https://thepharmadata.com/76th-world-health-assembly-adopts-first-ever-resolution-on-drowning-prevention/ 2023-05-30T12:33:00+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/WHO-2.webp https://thepharmadata.com/new-blood-biomarker-can-predict-if-cognitively-healthy-elderly-will-develop-alzheimers-disease/ 2023-05-30T12:27:41+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/disease.webp https://thepharmadata.com/pfizer-presents-scientific-advancements-from-its-leading-oncology-portfolio-at-asco-2023-annual-meeting/ 2023-05-27T05:33:14+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Meeting-2.webp https://thepharmadata.com/catalent-adds-new-cryogenic-capabilities-at-shiga-japan-facility-to-support-clinical-supply-demand-for-cell-and-gene-therapy-development/ 2023-05-27T05:22:43+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/Gene-Therapy.webp https://thepharmadata.com/more-ways-to-save-more-lives-for-less-money-world-health-assembly-adopts-more-best-buys-to-tackle-noncommunicable-diseases/ 2023-05-27T05:13:23+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/who-3.webp https://thepharmadata.com/who-urges-governments-to-stop-subsidizing-life-threatening-tobacco-crops/ 2023-05-27T05:10:09+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/WHO-2.webp https://thepharmadata.com/bolivia-conducts-a-simulation-exercise-to-strengthen-the-national-deployment-and-vaccination-plan-for-influenza-and-other-respiratory-viruses/ 2023-05-27T05:07:20+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/Vaccination.webp https://thepharmadata.com/imfinzi-plus-lynparza-and-imfinzi-alone-both-significantly-improved-progression-free-survival-in-advanced-endometrial-cancer-when-added-to-chemotherapy/ 2023-05-27T05:01:21+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/chemotherapy-2.webp https://thepharmadata.com/astrazeneca-will-highlight-momentum-of-practice-changing-cancer-medicines-across-its-robust-pipeline-at-asco-2023/ 2023-05-27T04:58:15+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/Medicines.webp https://thepharmadata.com/pfizers-paxlovid-receives-fda-approval-for-adult-patients-at-high-risk-of-progression-to-severe-covid-19/ 2023-05-27T04:55:20+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/COVID-19.webp https://thepharmadata.com/multivitamin-improves-memory-in-older-adults-study-finds/ 2023-05-27T04:52:51+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/memory.webp https://thepharmadata.com/capturing-transporter-structure-paves-the-way-for-drug-development/ 2023-05-27T04:48:27+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/drug-development.webp https://thepharmadata.com/european-study-finds-the-abbott-cardiomems-sensor-results-in-improved-quality-of-life-and-44-reduction-in-heart-failure-hospitalizations/ 2023-05-27T04:43:09+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/HOSPITALIZATIONS.webp https://thepharmadata.com/lilly-esg-report-highlights-progress-towards-sustainability-goals/ 2023-05-23T05:03:49+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/REPORT-scaled.webp https://thepharmadata.com/teva-to-present-data/ 2023-05-23T05:00:19+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Meeting-2.webp https://thepharmadata.com/who-launches-global-network-to-detect-and-prevent-infectious-disease-threats/ 2023-05-23T04:46:56+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/infectious.webp https://thepharmadata.com/abbott-unveils-late-breaking-data-showing-the-worlds-first-dual-chamber-leadless-pacemaker-study-met-all-three-primary-endpoints/ 2023-05-23T04:43:17+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/BREAKING-DATA.webp https://thepharmadata.com/high-school-scientists-and-engineers-win-nearly-9-million-at-the-regeneron-international-science-and-engineering-fair-2023/ 2023-05-20T05:47:35+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Internationally.webp https://thepharmadata.com/seventy-sixth-world-health-assembly-to-focus-on-saving-lives-driving-health-for-all-as-who-turns-75/ 2023-05-20T05:38:58+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/WHO.webp https://thepharmadata.com/abbott-receives-fda-approval-for-tactiflex-ablation-catheter-for-treatment-of-abnormal-heart-rhythm/ 2023-05-20T05:36:57+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/treatment-_2_-scaled.webp https://thepharmadata.com/roches-btk-inhibitor-fenebrutinib-significantly-reduced-brain-lesions-in-people-with-relapsing-forms-of-multiple-sclerosis/ 2023-05-18T05:24:35+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/brain.webp https://thepharmadata.com/who-congratulates-benin-and-mali-for-eliminating-trachoma-as-a-public-health-problem/ 2023-05-18T05:13:55+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/WHO.webp https://thepharmadata.com/astrazeneca-showcases-scientific-advances-across-rare-and-malignant-haematological-conditions-at-eha-2023/ 2023-05-18T05:09:45+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/scientific.webp https://thepharmadata.com/amgen-responds-to-ftc-action-re-proposed-acquisition-of-horizon-therapeutics/ 2023-05-18T05:06:07+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/THERAPEUTICS.webp https://thepharmadata.com/new-sandoz-board-of-directors-appointed/ 2023-05-15T11:16:14+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/appointed.webp https://thepharmadata.com/teva-shares-progress-toward-access-to-medicines-and-environmental-commitments-meeting-and-exceeding-several-esg-targets-ahead-of-schedule/ 2023-05-15T11:13:13+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/Medicines.webp https://thepharmadata.com/positive-data-from-two-phase-3-dupixent-dupilumab-trials-in-prurigo-nodularis-published-in-nature-medicine/ 2023-05-15T11:08:02+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/Nature-Medicine.webp https://thepharmadata.com/roche-launches-institute-of-human-biology-to-accelerate-breakthroughs-in-rd-by-unlocking-the-potential-of-human-model-systems/ 2023-05-15T11:01:18+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/Biology.webp https://thepharmadata.com/thermo-fisher-scientific-pfizer-partner-to-expand-localized-access-to-next-generation-sequencing-based-testing-for-cancer-patients-in-international-markets/ 2023-05-15T10:55:23+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Cancer-Vaccine.webp https://thepharmadata.com/sandoz-strengthens-pipeline-expansion-through-partnership-to-develop-and-manufacture-multiple-biosimilars/ 2023-05-15T10:52:30+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/strengthens.webp https://thepharmadata.com/gsk-presents-pivotal-data-at-espid-confirming-effectiveness-of-its-5-in-1-meningococcal-abcwy-vaccine-candidate-with-demonstrated-coverage-against-a-panel-of-110-menb-strains/ 2023-05-15T10:46:57+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/vaccine-scaled.webp https://thepharmadata.com/gilead-strengthens-early-pipeline-in-oncology-and-inflammation-through-the-acquisition-of-xinthera/ 2023-05-15T10:44:32+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/Oncology-2.webp https://thepharmadata.com/chmp-adopts-positive-opinion-recommending-hepcludex-bulevirtide-for-full-marketing-authorization-for-the-treatment-of-hepatitis-delta-virus-hdv/ 2023-05-15T10:41:15+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/Hepatitis-Delta-Virus.webp https://thepharmadata.com/four-analyses-of-data-for-rebyota-fecal-microbiota-live-jslm-the-first-fda-approved-microbiome-based-treatment-for-the-prevention-of-recurrent-c-difficile-infection-presented/ 2023-05-15T10:37:43+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/Infection.webp https://thepharmadata.com/lilly-discloses-first-in-class-interim-phase-2-data-in-pediatric-patients-and-new-analysis-from-phase-3-program-in-adult-patients-for-mirikizumab-in-ulcerative-colitis/ 2023-05-15T10:28:14+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/Adult-Patients.webp https://thepharmadata.com/boehringer-ingelheim-begins-clinical-development-of-first-in-class-treatment-for-fibrotic-diseases/ 2023-05-15T10:19:11+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/Clinical.webp https://thepharmadata.com/152-million-babies-born-preterm-in-the-last-decade/ 2023-05-15T10:13:46+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/babies-bor.webp https://thepharmadata.com/statement-on-the-fifteenth-meeting-of-the-ihr-2005-emergency-committee-on-the-covid-19-pandemic/ 2023-05-15T10:10:09+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/Emergency.webp https://thepharmadata.com/uae-and-who-deliver-air-lift-of-critical-medical-supplies-to-sudan/ 2023-05-15T10:07:52+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/medical.webp https://thepharmadata.com/farxiga-extended-in-the-us-to-reduce-risk-of-cardiovascular-death-and-hospitalisation-for-heart-failure-to-a-broader-range-of-patients/ 2023-05-15T09:58:47+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/heart-failure-scaled.webp https://thepharmadata.com/koselugo-approved-in-china-for-paediatric-patients-with-neurofibromatosis-type-1-and-plexiform-neurofibromas/ 2023-05-15T09:53:53+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Approvals.webp https://thepharmadata.com/syneos-health-appoints-michael-bonello-as-chief-financial-officer/ 2023-05-03T06:56:39+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/Appoints-_2_.webp https://thepharmadata.com/boehringer-ingelheim-and-german-chancellor-olaf-scholz-lay-the-foundation-stone-for-the-285-million-eur-innovation-center/ 2023-05-03T06:45:00+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/million.webp https://thepharmadata.com/new-survey-results-show-health-systems-starting-to-recover-from-pandemic/ 2023-05-03T06:39:31+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/survey.webp https://thepharmadata.com/african-parliamentarians-rally-to-boost-life-saving-laws-regulations-on-road-safety/ 2023-05-03T06:35:36+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/rally.webp https://thepharmadata.com/up-to-73-of-atopic-dermatitis-patients-taking-lillys-lebrikizumab-had-improved-or-cleared-skin-on-face-or-hands-in-new-analysis/ 2023-05-01T12:28:36+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/Cleared-Skin.webp https://thepharmadata.com/bristol-myers-squibbs-transcend-fl-and-transcend-nhl-001-studies-of-breyanzi-lisocabtagene-maraleucelin-relapsed-or-refractory-follicular-lymphoma-and-mantle-cell-lymphoma-meet-primary-endp/ 2023-05-01T12:23:07+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/lymphoma.webp https://thepharmadata.com/public-consultation-of-experts-to-join-the-guideline-development-group-gdg-for-defeating-meningitis-by-2030-roadmap-meningitis-diagnosis-treatment-and-care-guidelines/ 2023-05-01T12:21:05+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/treatment.webp https://thepharmadata.com/teva-and-medincell-announce-fda-approval-of-uzedy-risperidone-extended-release-injectable-suspension-a-long-acting-subcutaneous-atypical-antipsychotic-injection-for-the-treatment-of-schiz/ 2023-04-29T06:27:01+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Announcement.webp https://thepharmadata.com/update-on-fda-advisory-committee-vote-on-lynparza-olaparib-plus-abiraterone-and-prednisone-or-prednisolone-in-first-line-metastatic-castration-resistant-prostate-cancer/ 2023-04-29T05:11:53+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Vote.webp https://thepharmadata.com/update-on-fda-advisory-committee-vote-on-lynparza-plus-abiraterone-for-metastatic-castration-resistant-prostate-cancer/ 2023-04-29T05:02:17+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Update.webp https://thepharmadata.com/lillys-tripeptide-achieved-up-to-15-7-weight-loss-in-adults-with-obesity-or-overweight-and-type-2-diabetes-in-surmount-2/ 2023-04-27T11:47:48+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/weight-loss-scaled.webp https://thepharmadata.com/hart-scott-rodino-waiting-period-expires-for-sanofis-acquisition-of-provention-bio-inc/ 2023-04-27T11:43:41+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Hart-Scott-Rodino-scaled.webp https://thepharmadata.com/chmp-recommends-eu-approval/ 2023-04-27T11:34:24+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/approval.webp https://thepharmadata.com/novartis-phase-iii-appoint-pnh-trial-shows/ 2023-04-27T11:31:53+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/treatment-_2_-scaled.webp https://thepharmadata.com/bristol-myers-squibb-announces-leadership-transition-plan/ 2023-04-27T11:23:05+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Announces-2.webp https://thepharmadata.com/bristol-myers-squibb-receives-positive-chmp/ 2023-04-27T11:21:59+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Approvals.webp https://thepharmadata.com/bristol-myers-squibb-strengthens-cell-therapy-capabilities-by-adding-new-u-s-manufacturing-facility-for-viral-vector-production/ 2023-04-27T11:20:12+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Therapy-scaled.webp https://thepharmadata.com/boehringer-ingelheim-inaugurates-the-largest-european-development-center-for-biotechnology/ 2023-04-25T05:36:34+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/biotechnology.webp https://thepharmadata.com/lilly-to-divest-baqsimi-to-amphastar/ 2023-04-25T05:33:39+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Pharmaceuticals.webp https://thepharmadata.com/quizartinib-nda-review-for-patients-with-newly-diagnosed-flt3-itd-positive-aml-extended-by-fda/ 2023-04-25T05:21:41+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Review.webp https://thepharmadata.com/amgen-announces-webcast-of-2023-first-quarter-financial-results/ 2023-04-25T05:15:42+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Announces-2.webp https://thepharmadata.com/abbvie-announces-late-breaking-results/ 2023-04-25T05:12:04+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Announcement.webp https://thepharmadata.com/a-backpack-full-of-multiple-sclerosis-therapy/ 2023-04-22T10:34:53+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/multiple-sclerosis-therapy.webp https://thepharmadata.com/cocktail-of-modified-antibodies-provides-strong-effect-against-sars-cov-2/ 2023-04-22T10:32:37+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/antibodies.webp https://thepharmadata.com/clinical-trial-begins-using-car-t-cells-to-potentially-cure-hiv/ 2023-04-22T10:31:17+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/cells.webp https://thepharmadata.com/anti-obesity-medications-could-be-sold-for-lower-prices/ 2023-04-22T10:27:13+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/obestity.webp https://thepharmadata.com/t-cell-vaccine-for-covid-19-may-last-longer-than-current-vaccines/ 2023-04-22T10:24:00+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/t-cell.webp https://thepharmadata.com/who-releases-new-guide-on-developing-national-programs-for-age-friendly-cities-and-communities/ 2023-04-22T10:22:29+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/programs.webp https://thepharmadata.com/how-cancer-evades-immune-system-detection-and-spreads/ 2023-04-22T10:20:24+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/cancer.jpg https://thepharmadata.com/who-releases-first-ever-standard-on-universal-access-to-rapid-tb-diagnostics/ 2023-04-22T10:19:33+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/TB-diagnostics.webp https://thepharmadata.com/new-therapy-harnesses-patients-blood-cells-to-fight-tumors/ 2023-04-22T10:18:12+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/New-therapy-harnesses-patients-blood-cells-to-fight-tumors.webp https://thepharmadata.com/who-unicef-have-started-the-immunization-annual-data-collection-process/ 2023-04-22T10:16:54+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Immunization.webp https://thepharmadata.com/researchers-leverage-cell-self-destruction-to-treat-brain-tumors/ 2023-04-22T10:15:21+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/brain-tumors.webp https://thepharmadata.com/cycpeptmpdb-a-database-aimed-at-promoting-drug-design-using-cyclic-peptides/ 2023-04-22T10:13:28+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/drug.webp https://thepharmadata.com/tumor-avatars-to-fight-colorectal-cancer/ 2023-04-22T10:10:40+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/colorectal-cancer.webp https://thepharmadata.com/imfinzi-based-treatment-before-and-after-surgery-reduced-the-risk-of-disease-recurrence-progression-events-or-death-by-32-in-resectable-non-small-cell-lung-cancer-in-the-aegean-phase-iii-trial/ 2023-04-22T10:07:34+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/lung-cancer.webp https://thepharmadata.com/gepotidacins-positive-phase-iii-data-shows-potential-to-be-the-first-in-a-new-class-of-oral-antibiotics-for-uncomplicated-urinary-tract-infections-in-over-20-years/ 2023-04-22T10:06:56+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/oral-antibiotics.webp https://thepharmadata.com/u-s-food-and-drug-administration-issues-complete-response-letter-for-mirikizumab/ 2023-04-22T10:06:10+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Food-and-Drug.webp https://thepharmadata.com/sandoz-receives-approval-by-european-commission-for-hyrimoz-adalimumab-high-concentration-formulation/ 2023-04-22T10:05:46+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/approval.webp https://thepharmadata.com/ultomiris-recommended-for-approval-in-the-eu-by-chmp-for-the-treatment-of-adults-with-neuromyelitis-optica-spectrum-disorder-nmosd/ 2023-04-22T10:04:35+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/treatment.webp https://thepharmadata.com/pfizer-invites-shareholders-to-attend-virtual-only-2023-annual-meeting-of-shareholders-on-april-27/ 2023-04-22T10:04:12+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Meeting.webp https://thepharmadata.com/gsk-reaches-agreement-to-acquire-late-stage-biopharmaceutical-company-bellus-health/ 2023-04-22T09:59:50+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/agreement.webp https://thepharmadata.com/update-to-contractual-arrangements-between-astrazeneca-swedish-orphan-biovitrum-ab-and-sanofi/ 2023-04-22T09:59:43+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Update-2.webp https://thepharmadata.com/fda-approves-cell-therapy-for-patients-with-blood-cancers-to-reduce-risk-of-infection-following-stem-cell-transplantation/ 2023-04-22T09:58:14+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/blood-cancers.webp https://thepharmadata.com/mercks-keytruda-pembrolizumab-plus-chemotherapy-significantly-improved-overall-survival-compared-to-chemotherapy-alone-in-patients-with-advanced-or-unresectable-biliary-tract-cancer/ 2023-04-22T09:52:39+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Chemotherapy.webp https://thepharmadata.com/merck-strengthens-immunology-pipeline-with-acquisition-of-prometheus-biosciences-inc/ 2023-04-22T09:49:38+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Biosciences.webp https://thepharmadata.com/bayer-to-present-latest-research-across-its-advancing-oncology-portfolio-at-aacr-2023-annual-meeting/ 2023-04-22T09:40:46+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Meeting-2.webp https://thepharmadata.com/fda-approves-mercks-keytruda-pembrolizumab-in-combination-with-padcev-enfortumab-vedotin-ejfv-for-first-line-treatment-of-certain-patients-with-locally-advanced-or-metastatic/ 2023-04-22T09:39:37+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Metastatic-Urothelial-Cancer.webp https://thepharmadata.com/fda-approves-roches-policy-in-combination-with-r-chp-for-people-with-certain-types-of-previously-untreated-diffuse-large-b-cell-lymphoma/ 2023-04-22T09:38:25+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/lymphoma.webp https://thepharmadata.com/merck-named-one-of-fortunes-2023-100-best-companies-to-work-for/ 2023-04-22T09:38:05+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Best.webp https://thepharmadata.com/aspect-biosystems-and-novo-nordisk-enter-partnership-to-develop-bioprinted-tissue-therapeutics-for-diabetes-and-obesity/ 2023-04-22T09:37:59+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/diabetes.webp https://thepharmadata.com/sanofi-astrazeneca-and-sobi-simplify-contractual-agreements/ 2023-04-22T09:37:18+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/agreements.webp https://thepharmadata.com/two-fitusiran-phase-3-studies-published-in-the-lancet-and-the-lancet-haematology-highlight-potential-to-address-unmet-needs-across-all-types-of-hemophilia/ 2023-04-22T09:36:49+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/publish.webp https://thepharmadata.com/update-on-imbruvica-ibrutinib-u-s-accelerated-approvals-for-mantle-cell-lymphoma-and-marginal-zone-lymphoma-indications/ 2023-04-22T09:36:22+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Approvals.webp https://thepharmadata.com/merck-and-eisai-provide-update-on-phase-3-trials-of-keytruda-pembrolizumab-plus-lenvima-lenvatinib-in-certain-patients-with-advanced-melanoma-leap-003-and-metastatic-colorectal-cance/ 2023-04-22T09:35:31+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Update.webp https://thepharmadata.com/mrna-4157-v940-an-investigational-personalized-mrna-cancer-vaccine-in-combination-with-keytruda-pembrolizumab-receives-prime-scheme-designation-from-the-european-medicines-agency-for-adjuva/ 2023-04-22T09:33:41+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Cancer-Vaccine.webp https://thepharmadata.com/merck-ranked-no-1-in-the-pharmaceutical-industry-among-barrons-100-most-sustainable-u-s-companies-2023/ 2023-04-22T09:29:28+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/U.S.webp https://thepharmadata.com/astrazeneca-advances-its-pipeline-and-highlights-progress-in-immuno-oncology-adcs-cell-therapy-and-epigenetics-at-aacr/ 2023-04-22T09:19:31+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/oncology.webp https://thepharmadata.com/eccmid-data-reinforces-astrazenecas-commitment-to-transform-protection-for-the-most-vulnerable-by-advancing-science-in-vaccines-and-immune-therapies/ 2023-04-22T09:16:55+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/immune-therapies.webp https://thepharmadata.com/lynparza-and-imfinzi-combination-improved-progression-free-survival-in-newly-diagnosed-patients-with-advanced-ovarian-cancer-without-tumour-brca-mutations-in-duo-o-phase-iii-trial/ 2023-04-22T09:12:36+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/cancer.webp https://thepharmadata.com/update-on-imbruvica-ibrutinib-u-s-accelerated-approvals-for-mantle-cell-lymphoma-and-marginal-zone-lymphoma-indications-2/ 2023-04-22T09:04:34+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Update.webp https://thepharmadata.com/erleada-apalutamide-first-and-only-next-generation-androgen-receptor-inhibitor-with-once-daily-single-tablet-option-now-available-in-the-u-s/ 2023-04-22T08:59:19+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Single-Tablet.webp https://thepharmadata.com/new-data-from-pivotal-studies-with-aflibercept-8-mg/ 2023-04-22T08:55:10+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Research.webp https://thepharmadata.com/bayer-to-invest-a-total-of-60-million-euros-in-its-ukrainian-seed-production-site/ 2023-04-22T08:47:33+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Ukrainian.webp https://thepharmadata.com/bayers-grants4ag-program-awards-21-crop-science-research-grants-for-2023/ 2023-04-22T08:45:18+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Science-Research.webp https://thepharmadata.com/internationally-renowned-experts-form-independent-bayer-bioethics-council/ 2023-04-22T08:43:22+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Internationally.webp https://thepharmadata.com/elisabeth-moreno-to-join-sanofis-diversity-equity-and-inclusion-board/ 2023-04-22T08:37:28+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/join.webp https://thepharmadata.com/sanofi-announces-withdrawal-and-refiling-of-premerger-notification-and-report-form-under-the-hsr-act-and-extension-of-tender-offer-to-acquire-provention-bio-inc/ 2023-04-22T08:32:55+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Announces-2-1.webp https://thepharmadata.com/vekluryremdesivir-efficacy-and-safety-profile-further-demonstrated-in-vulnerable-patient-populations/ 2023-04-22T07:58:55+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Patient.webp https://thepharmadata.com/bristol-myers-squibb-submits-application-for-abecma-a-car-t-cell-therapy-for-patients-with-relapsed-or-refractory-multiple-myeloma-who-have-received-at-least-two-prior-therapies/ 2023-04-22T07:53:57+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Application-2.webp https://thepharmadata.com/novo-nordisk-raises-sales-and-operating-profit-outlook-for-2023/ 2023-04-22T07:45:56+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/raises-sales.webp https://thepharmadata.com/roches-tecentriq-plus-avastin-reduced-the-risk-of-cancer-returning-in-people-with-certain-types-of-adjuvant-liver-cancer-in-a-phase-iii-study/ 2023-04-22T07:28:30+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/liver-cancer.webp https://thepharmadata.com/roche-data-highlights-the-strength-of-the-ophthalmology-portfolio-and-commitment-to-advancing-eye-care-at-arvo-2023/ 2023-04-22T07:26:23+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/ophthalmology-portfolio.webp https://thepharmadata.com/amgen-wins-patent-appeal-on-otezla-apremilast/ 2023-04-22T07:21:18+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/WINS.webp https://thepharmadata.com/lilly-to-make-record-breaking-investment-in-indiana-manufacturing-facilities/ 2023-04-22T07:14:26+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Investment-scaled.webp https://thepharmadata.com/lilly-confirms-date-and-conference-call-for-first-quarter-2023-financial-results-announcement/ 2023-04-22T07:06:39+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Announcement.webp https://thepharmadata.com/teva-to-host-conference-call-to-discuss-first-quarter-2023-financial-results-at-8-a-m-et-on-may-10-2023/ 2023-04-22T07:02:26+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Conference-Call.webp https://thepharmadata.com/complete-response-letter-received-for-avt02-biologics-license-application/ 2023-04-22T06:59:53+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Application.webp https://thepharmadata.com/teva-to-present-new-data-on-once-daily-austedo-xr-deutetrabenazine-extended-release-tablets-at-the-2023-american-academy-of-neurology-annual-meeting/ 2023-04-22T06:57:19+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Meeting.webp https://thepharmadata.com/abbvie-announces-european-commission-approval-of-rinvoq-upadacitinib-for-the-treatment-of-moderately-to-severely-active-crohns-disease/ 2023-04-22T06:51:58+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Announces-2.webp https://thepharmadata.com/abbvie-invites-college-students-living-with-cystic-fibrosis-to-apply-for-the-abbvie-cf-scholarship-for-the-2023-2024-academic-school-year/ 2023-04-22T06:48:29+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Apply.webp https://thepharmadata.com/coolsculpting-elite-announces-first-ever-coolmonth/ 2023-04-22T06:39:17+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Appoints-1.webp